Stay updated on Nintedanib for Progressive Fibrosing ILD Clinical Trial
Sign up to get notified when there's something new on the Nintedanib for Progressive Fibrosing ILD Clinical Trial page.

Latest updates to the Nintedanib for Progressive Fibrosing ILD Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check25 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision: v3.4.2 was added. The prior government funding lapse notice and Revision: v3.4.1 were removed.SummaryDifference0.2%

- Check60 days agoChange DetectedAdded a site-wide government funding notice and updated the revision tag to v3.4.1, replacing the previous v3.4.0 revision.SummaryDifference0.2%

- Check68 days agoChange DetectedShow glossary added; metadata updates include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and Revision: v3.4.0, while the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check103 days agoChange DetectedLocations section updated to include a broader list of study sites across the United States and Canada, and a revision tag v3.3.3.SummaryDifference1%

Stay in the know with updates to Nintedanib for Progressive Fibrosing ILD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nintedanib for Progressive Fibrosing ILD Clinical Trial page.